AMAKEM
Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem's product pipeline is based on its unique รขโฌหLocalized Drug Action' platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducing side effects.
AMAKEM
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Diepenbeek, Limburg, Belgium
Country:
Belgium
Website Url:
http://www.amakem.com
Total Employee:
11+
Status:
Active
Contact:
32-(0)-11-286-982
Email Addresses:
[email protected]
Total Funding:
25.23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Nginx
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Rhovac ApS
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Current Employees Featured
Founder
Investors List
Omnes Capital
Omnes Capital investment in Series A - Amakem
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series A - Amakem
Limburgse Reconversie Maatschappij
Limburgse Reconversie Maatschappij investment in Series A - Amakem
Forbion Capital Partners
Forbion Capital Partners investment in Series A - Amakem
Official Site Inspections
http://www.amakem.com
- Host name: ec2-18-119-154-66.us-east-2.compute.amazonaws.com
- IP address: 18.119.154.66
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
